Keio Researcher to Launch Clinical Trial on Repositioned AD Treatment in April

Prof. Toru Mizushima, Faculty of Pharmacy, Keio University A researcher at Keio University says his team plans to kick off a clinical trial on Eisai’s stomach medicine Selbex (teprenone) for the treatment of Alzheimer’s disease (AD) in April - a...read more